The presence of these ITC conjugates in the synthesized samples was verified using an HPLC (Agilent HP1100 series, Agilent Technologies) ion trap mass spectrometer (ESQUIRE-6000 system, Bruker) using a Nucleodur Sphinx RP column (250 4.6 mm 5 m)
Disclosures: Andrea Mospan: Nothing to Disclose, Breda Munoz: Nothing to Disclose, Heather Morris: Nothing to Disclose, Aarth Sheth: Nothing to Disclose, Rakesh Luthra: Nothing to Disclose 1080 VALIDATION AND EPIDEMIOLOGIC DEFINITION OF THE NOVEL STEATOTIC LIVER DISEASE NOMENCLATURE IN A NATIONAL COHORT WITH CIRRHOSIS Catherine Mezzacappa 1 Pedro Ochoa-Allemant 2 Marina Serper 3 Tamar Taddei 1 Binu John 4 David Kaplan 2 Nadim Mahmud 5 , 1 Yale University, 2 University of Pennsylvania, 3 University of Pennsylvania Health System, 4 University of Miami, 5 Hospital of the University of Pennsylvania Background: Novel steatotic liver disease (SLD) definitions were introduced in 2023 with a diagnostic algorithm based on the presence of cardiometabolic risk factors (CMRFs) and thresholds for alcohol exposure to define metabolic dysfunction-associated SLD (MASLD), alcohol-associated liver disease (ALD), and metabolic and alcohol-associated liver disease (MetALD)
Vrije radicalen zijn instabiele moleculen die ontstaan door oxidatie en kunnen schade aanrichten aan je cellen
doi: 10.1038/s41575-020-0273-0 130 ShuaiKLiuB
